A Full Service Intellectual Property Firm

Safeguarding innovation demands proactive IP counsel known for thought leadership and creative legal strategies. Safeguarding innovation demands Oblon.

Select an Attorney Select a Service Contact Us
Firm News

Lisa Mandrusiak Authored 4th Most Read Article in U.S. via Mondaq Network

In September 2019, Lisa M. Mandrusiak came 4th as the contributor most read in United States with the article Thinking Outside The (Utility Patent) Box - Don't Overlook Design Patent Protection In The Life Sciences via the Mondaq distribution network.

More
Firm News

Oblon Ajinomoto Litigation Team Receives Favorable Decision

Oblon obtained a favorable claim-construction result for its client, Ajinomoto Co., in the U.S. District Court for the District of Delaware. The underlying opinion determined that patent claims asserted by Kyowa Hakko Bio against Ajinomoto are indefinite.

More
Firm News

Oblon Attorney Named to "Top 50 Women in PTAB Trials"

Lisa Mandrusiak is listed as one of the top 50 Women in PTAB Trials by the PTAB Bar Association. The PTAB Bar Association published its inaugural Top 50 Women in PTAB Trials list.

More

How Foreign Patent Infringers Are Subject to Jurisdiction in the United States

More

The Flip Side of Reasonable Expectation of Success is Unpredictability

The Federal Circuit in a precedential opinion in Osai Pharmaceuticals, LLC v Apotex et al (Fed. Cir., October 4, 2019) http://www.cafc.uscourts.gov/sites/default/files/opinions-orders/18-1925.Opinion.10-4-2019.pdfreversed the USPTO's determination of obviousness in an IPR for patent claims directed to the treatment of non-small cell lung cancer (NSCLC). Just reading the background of the first three or four pages of the decision, it was already apparent that the Court was not going to be affirming the PTAB's decision. Notably:

More

USPTO Proposed Revisions to Rules on Patent Term Adjustment

More

U.S. Bar/JPO Liaison Council Meeting

David Longo will participate in the US Bar/JPO Liaison Council Meeting as a Virginia State Bar delegate on October 17-18th, in Tokyo, Japan.

More

2019 AIPLA Annual Meeting

Several Oblon attorneys will be attending the 2019 AIPLA Annual Meeting on October 24-26th at the Gaylord National Resort & Convention Center.

More

SEBIO Investor & Partnering Forum 2019

Oblon is a sponsor of the SEBIO Investor & Partnering Forum 2019 that will be held on November 6-7th at The Biltmore in Miami-Coral Gables, Florida. The conference provides an unparalleled opportunity to meet key decision makers in the regional and national life science and medical technology communities. More than 300 biotech and medtech investors, corporate executives, university representatives, and entrepreneurs will attend this year.

More

Oblon Professionals attend Nats Game with our International Guests

Oblon professionals took International Guests to a Nationals baseball game at Nats Park in Washington, DC.

More

Eleven Oblon Attorneys Recognized as Best Lawyers 2020

Eleven Oblon attorneys have been named to the 2020 edition of Best Lawyers in America.

More

Oblon Launches Life Sciences Blog

Today, Oblon launched its Life Sciences blog, www.lifesciencesipblog.com , which is designed to report and comment on Intellectual property matters related to the life sciences industry.

More